CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 139 enrolled
Drug / intervention
additional soft tissue in neck dissectionsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03237195
NCT03237195N/ACompleted
CompareCT.gov

Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection Specimen in Its Entirety.

University of Mississippi Medical Center·observational·Posted Aug 2, 2017·Updated Feb 20, 2018

In Brief

An observational study evaluating additional soft tissue in neck dissections for Metastasis. Completed, enrolled 139 participants across 1 site.

Detailed Summary

Most patients with cancer of the head and neck are offered surgical resection of the primary tumor. In order to determine how the tumor will eventually behave, along with the resection of the primary tumor, lymph nodes present in the neck are also dissected. Different institutes have different protocol on handling of the specimen that is received by the pathology labs after dissection of the neck. The investigators intend to analyze the protocol that they use to evaluate the neck dissection specimen.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMetastasis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 2, 2017
Enrollment StartJan 1, 2013
Primary CompletionDec 31, 2016
Study CompletionDec 31, 2017
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 8.9 years ago

Interventions

additional soft tissue in neck dissectionsother

Evaluation of submission of additional soft tissue in neck dissections for head and neck squamous cell carcinomas